BACKGROUND
The prevalence of Non-alcoholic fatty liver disease (NAFLD) including non-alcoholic steatohepatitis (NASH) has increased by 15-39% worldwide, but no pharmaceutical therapeutics exists.
UNASSIGNED
This study investigated anti-hepatosteatotic effect of CGplus (a standardized herbal